Green Tobacco Sickness
There was no scientific study conducted on Oriental tobacco (Small-Leaf Nicotine Rate Average: around 1%) until 2023.
For the first time, a scientific study has been initiated by the industry in cooperation to shed light on this issue, and during this project, an average of 8 samples were collected from 330 producers during the cropping period by the independent project partner Euroline and taken to the ARGEFAR Laboratory, another independent partner institution, and preserved under appropriate conditions, and cotinine and creatinine analyses were started. At the end of the analysis process, the results obtained by the project manager ARGEFAR will be evaluated and the scientific report will be shared with the tobacco sector.
Presentation on Green Tobacco Sickness (GTS) in Oriental Tobacco Gains Significant Attention at CORESTA
CORESTA (Centre de Coopération pour les Recherches Scientifiques Relatives au Tabac / Cooperation Centre for Scientific Research Relative to Tobacco) held in Scotland / Edinburgh between 13-17 October 2024 At the Congress, the scientific study on ‘Determination of the Risk of Green Tobacco Sickness in Oriental Tobacco’ conducted by the Occupational Health and Safety Working Group, one of the sustainability working groups established under the Aegean Tobacco Exporters’ Association, was evaluated as scientifically complete and exemplary.
This study, carried out in collaboration with Ege University/Argefar, stands out not only for protecting tobacco workers’ health and contributing to sustainable agricultural practices but also for being more extensive and informative than any other global research conducted on Green Tobacco Sickness to date.
The study was presented at the congress by Project Director Prof. Dr. Burak Cem Soner.
Representing the Aegean Tobacco Exporters Association at the congress were Working Group Leaders Ergün Bademci, Demet Ayşegül Ülkü, and Damla Baysal Sivritepe
